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Background: Low birth weight and gestational maternal smoking have been linked with reduced lung
function in children in many cross sectional studies. However, these associations have not yet been
assessed with repeated measurements of lung function. Our aim was to investigate the effects of birth
weight, gestational age, and gestational maternal smoking on lung function in children at age 10 and 18
years.
Methods: In the Isle of Wight birth cohort spirometry was performed at age 10 and 18 years. Information
on birth weight and gestational age were obtained from hospital records. Mothers were asked about
smoking during pregnancy. We employed linear mixed models to estimate the effect of these risk factors
on repeated measurements of lung function. We considered maternal asthma, sex, neonatal intensive
care unit admission, height, socio-economic status, personal smoking in participants at age 18, body
mass index and environmental tobacco smoke exposure as potential confounders. Finally, we used path
analysis to determine links between birth weight, gestational age and gestational maternal smoking on
lung function at age 10 and 18 years.
Results: Linear mixed models showed that with every 1 kg increase in birth weight, Forced expiratory
volume in one second (FEV1) increased by 42.6 ± 17.2 mL and Forced expiratory ﬂow between 25% and
75% (FEF25e75) of Forced vital capacity (FVC) increased by 95.5 ± 41.2 mL at age 18 years after adjusting
for potential confounders. Path analysis suggested that birth weight had positive direct effects on FEV1
and FEF25e75 and positive indirect effect on FVC at 10 years which were carried forward to 18 years.
Additionally, results also suggested a positive association between gestational age and FEV1, FVC and
FEF25e75 at ages 10 and 18 years and an inverse association between gestational smoke exposure and
FEV1/FVC ratio and FEF25e75 at age 18 years.
Conclusions: Higher birth weight and gestational age were associated with higher FEV1, FVC and FEF25e75
and maternal smoking during pregnancy was associated with reduced FEV1/FVC ratio and FEF25e75. The
use of path analysis can improve our understanding of underlying “causal” pathways among different
prenatal and childhood factors that affect lung function in both pre-adolescent and adolescent periods.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).al Center, Division of General
NY 10032, USA.
alte.p@gmail.com (P. Balte),
soton.ac.uk (G. Roberts), r.j.
frances.mitchell@iow.nhs.uk
Ltd. This is an open access article u1. Introduction
The ‘Barker hypothesis’ also known as ‘fetal origins of adult
disease’ hypothesis, states that adverse exposures encountered
during intrauterine life can result in permanent changes in physi-
ology which may result in increased risk of chronic diseases in
adulthood [1]. Barker et al. showed that, fetal and infant growthsnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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(LBW) may increase the risk of death from chronic obstructive lung
disease [2]. Other studies have also shown that LBW and very low
birth weight (VLBW) are associated with reduced lung function in
children [3e7]. Two more studies have found a positive relation-
ship between continuous birth weight measures and lung function
in children [8,9]. In adults, the ﬁndings are mixed, some studies
reported a signiﬁcant positive linear trend between birth weight
and lung function [10e13], while other studies found no association
[14].
The process of lung development begins in the intrauterine
period and continues well into late adolescence/early adulthood.
Therefore, intrauterine exposures affecting lung development
during fetal life, for example maternal smoking, may have a long
term negative impact on lung function. Additionally, maternal
smoking during pregnancy is known to result in pre-term births
and LBW in full term babies [15,16]. Thus, maternal smoking during
pregnancy, gestational age and birth weight are correlated and
birth weight may be in the pathway between in-utero exposure to
maternal smoking and lung function. However, there is disagree-
ment on whether maternal smoking during pregnancy has inde-
pendent effect on reduction of lung function in childhood [17e19].
Previous studies while investigating association between birth
weight and lung function have adjusted for the effect of maternal
smoking during pregnancy without addressing the fact that birth
weight may be an intervening variable. Similarly, height which is a
signiﬁcant determinant of lung function may also act as an inter-
vening variable in the path between birth weight and lung function
as many pediatric studies have shown a positive association be-
tween birth weight and growth of height during childhood [20,21].
Lung function during childhood and adolescent periods is
determined by complex relationships between several factors that
need to be taken into account simultaneously. However, adjusting
for intervening variables as confounders not only distorts the causal
pathway but also leads to an over-adjustment bias [22]. The
inconsistent results in association between birth weight and lung
function in the above mentioned studies may be attributed to the
use of traditional regression analyses, which do not take into
consideration the directional or non-directional relationships be-
tween various observed factors. To elucidate these complex re-
lationships, use of path analysis provides a novel approach. A
variable representing the response in one equation can act as a risk
factor in another equation, thus allowing the inclusion of inter-
vening or mediating variables in the model. Finally, simultaneously
solving multiple linear regression equations generates direct, in-
direct and total effects of each variable on the outcome, which can
be used to develop a causal path diagram.
To gain better understanding of the relationship between birth
weight, maternal smoking, and lung function in children at age 10
and 18 years, we analyzed data from the Isle of Wight (IOW) birth
cohort. We explored these associations ﬁrst by using linear
regression, followed by linear mixed models and path analysis in
which we assessed complex relationships between different pre-
natal and childhood factors that may affect the association between
birth weight and lung function.
2. Materials and methods
2.1. Study population
Between January 1989 and February 1990, 1536 mothers/child
pairs were contacted to be enrolled in the IOW birth cohort. After
obtaining informed written consent 1456 were enrolled and
available for follow-up at 1, 2, 4, 10 and 18 years of age. Among
them, 1121 children were tested for spirometry either at 10(n ¼ 981) or 18 years of age (n ¼ 838) or both (n ¼ 698) The IOW
cohort is described in detail elsewhere [23e25].
2.2. Birth weight and other measurements
Information on birth weight, gestational age, and admission to
neonatal intensive care unit (NICU) were obtained from the hos-
pital records. Information on maternal smoking during gestation,
sex of the child, and maternal history of asthma was ascertained
after delivery. We considered maternal smoking during gestation,
maternal history of asthma, sex, admission to NICU, height, socio-
economic status (SES), personal smoking in children at age 18,
body mass index (BMI) and environmental tobacco smoke (ETS)
exposure at age 10 and 18 as potential confounders or intervening
variables. Information on the SES was based on the following three
variables: (a) the British socioeconomic classes (1e6) derived from
parental occupation reported at birth; (b) the number of children in
the index child's bedroom (collected at age 4 years); and (c) family
income at age 10 years [25]. Height and weight were measured
before spirometric tests at age 10 and 18 years; BMI was calculated.
To address the differential growth pattern in height in boys and
girls we considered an interaction term between height and sex.
Exposure to ETS at age 10 and 18 was inquired from questions of
“any smoking in the household”. Active smoking at age 18 years
was ascertained from the study participants at age 18.
2.3. Lung function
Lung function tests were conducted at 10 and 18 years of age.
Forced vital capacity (FVC), Forced expiratory volume in one second
(FEV1), Forced expiratory ﬂow between 25% and 75% of FVC
(FEF25e75) and Peak expiratory ﬂow rate (PEFR) were measured
using a Koko Spirometer and software with a portable desktop
device (both PDS Instrumentation, Louisville, KY, USA). Spirometry
was performed and evaluated according to the American Thoracic
Society (ATS) criteria. Children were required to be free of respi-
ratory infection for two weeks and not to be taking any oral corti-
costeroids and were advised to abstain from any b-agonist
medication for six hours and from caffeine intake for at least four
hours [23].
2.4. Statistical analysis
Firstly, to determine effects of birth weight and maternal
smoking during pregnancy on lung function at cross-sectional level
we used standard linear regression technique separately at ages 10
and 18 years. Next, we used linear mixed models for repeated
measurements on cohort of children who were tested for lung
function either at age 10 or18 years or both. Unstructured covari-
ance structure matrix was selected based on lowest Akaike infor-
mation criteria and the Bayesian Schwarz information criterion
after considering unstructured, compound symmetry and autore-
gressive covariance structure matrices. All models were adjusted
for above mentioned confounders. The models assessing the rela-
tionship betweenmaternal smoking in-utero and lung function and
gestational age and lung function were not adjusted for birth
weight. We selected the confounders that changed the estimates of
main exposures (birth weight, exposure to in-utero maternal
smoking and gestational age) by 10%. We also included an inter-
action term between sex and height since the relationship between
height and lung function varies by sex [26]. To control for type-I
error due to multiple comparisons the signiﬁcance level was set
at alpha ¼ 0.025 whenever interaction term between height and
sex was included in the model. Otherwise signiﬁcance level of
alpha ¼ 0.05 was maintained for rest of the models.
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we used multiple imputations to generate ten new datasets. All
datasets were analyzed separately for both linear regressions and
linear mixed models. Finally all results were combined and valid
statistical inferences were generated using MIANALYZE.
2.5. Path analysis
As mentioned earlier birth weight and height act as intervening
variables on two separate pathways frommaternal smoking during
pregnancy and lung function and linear mixed models do not
address the issue of intervening variables. Adjusting on these var-
iables may lead to biased estimates. Therefore, we explored the
relationships between birth weight, maternal smoking during
pregnancy and lung function at age 10 and 18 years by linear path
analysis using Covariance Analysis of Linear Structural Equations.
Since data on covariates was missing completely at random we
used Full Information Maximum Likelihood (FIML) method to
determine parameter estimates. The adequacy of model ﬁt was
determined by several statistics: a Chi-square p-value > 0.05 for the
difference between the theoretical and the empirical model,
comparative ﬁt index (CFI) > 90, adjusted goodness of ﬁt index
(GFI) > 90 and root mean square error of approximation
(RMSEA) < 0.06. The data were analyzed using the SAS statistical
package (version 9.3; SAS Institute, Cary, NC, USA).
3. Results
There were no signiﬁcant differences between full IOW cohort
and the sample of participants whowere tested for lung function at
either age [Table 1]. In total 1121 children had spirometry tests
done either at age 10 years (n ¼ 981) or 18 years (n ¼ 838) or both
(n ¼ 698). The average birth weight was 3.4 ± 0.5 kg and 22.7%
children were exposed to maternal smoking in-utero.
3.1. Linear regression at age 10 and 18 years of age
At 10 years of age, with every 1 kg increase in birth weight there
was a signiﬁcant increase in FEV1, FVC and FEF25e75 [Table 2]. There
was also a signiﬁcant increase in FEV1/FVC ratio with every one
week increase in gestational age but no signiﬁcant effect of
maternal smoking during pregnancy on lung function at age 10
years. At 18 years of age, birth weight showed a positive association
with FEV1 and FVC and those who were exposed to maternal
smoking in-utero had an increase in FVC and hence signiﬁcant
decrease in FEV1/FVC ratio.
3.2. Linear mixed models
Results from linear mixed models (repeated measurements)
showed that with every 1 kg increase in birth weight, FEV1 and
FEF25e75 increased by 42.6 ± 17.2 mL and 95.5 ± 41.2 mL, respec-
tively at age 18 years [Table 3]. The models were adjusted for
maternal smoking during pregnancy, sex, height, age, gestational
age, maternal history of asthma, admission to NICU, smoking at 18
years of age and the interaction between height and sex. We found
no effect of maternal smoking during pregnancy or gestational age
on any lung function parameters.
3.3. Path analysis
Figs. 1 and 2 illustrate statistically signiﬁcant direct effects (path
coefﬁcients) of each factor on FEV1 and FEF25e75, respectively.
Detailed information on direct and indirect effect of each factor on
lung function parameter is provided in the online supplement. InFig. 1, path coefﬁcients suggested a positive direct effect of birth
weight on FEV1 at age 10, but no direct effect at age 18 years.
However, since FEV1 at age 10 years has a positive direct effect on
FEV1 at age 18 years presumably the effect of birth weight on FEV1
at age 10 was carried forward (indirect effect) to age 18 years as
indicated by a positive total effect (directþ indirect) of birth weight
on FEV1 at 18 years (Table 2 in online supplement). On the other
hand, maternal smoking during pregnancy had no signiﬁcant direct
or indirect effects on FEV1 either at age 10 or 18 years (Tables 1 and
2 in online supplement); however, it may have an inverse indirect
effect on FEV1 through reduction in birth weight. Additionally,
gestational age also had positive indirect and total effects on FEV1
both at ages 10 and 18 years (Tables 1 and 2 in online supplement).
Fig. 2 shows that birth weight had a positive direct effect on
FEF25e75 at age 10, which was carried forward to age 18 years.
Another signiﬁcant ﬁnding was that of a direct negative effect of
exposure to maternal smoking in-utero on FEF25e75 at age 18 years
but not at age 10 years which was not seen in FEV1. Gestational age
also had a positive indirect effect on FEF25e75 at age 10 years but not
at age 18 years (Tables 1 and 2 in online supplement). We also
found that birth weight had a positive indirect effect on FVC at age
18 years and exposure to maternal smoking in-utero had a positive
direct effect on FVC and therefore negative direct effect on the FEV1/
FVC ratio (Table 2 in online supplement).
4. Discussion
We studied the IOW birth cohort to assess the association be-
tween birth weight and gestational smoking on lung function at 10
and 18 years. Using linear mixed models for repeated measure-
ments we found that there was signiﬁcant increase in FEV1 and
FEF25e75 with every 1 kg increase in birth weight at age 18 years
after adjusting for potential confounders. We did not ﬁnd any sig-
niﬁcant association of maternal smoking during pregnancy with
lung function after adjusting for other potential confounders. The
results of the linear path analysis were different from the linear
mixed models. Path analysis showed that birth weight had positive
effects not only on FEV1and FEF25e75 but also on FVC either directly
or indirectly through various pathways. Additionally, path analysis
also showed that maternal smoking during pregnancy had direct
negative associations with the FEV1/FVC ratio (due to increase in
FVC) and FEF25e75 and that gestational age was positively linked
with FEV1 and FVC through birth weight.
4.1. Relationship between birth weight and lung function in
children
Most previous studies assessing relationship between birth
weight and lung function conducted in children focused on inves-
tigating effects of LBW and VLBWon respiratory health, since these
are well-known risk factors for increased morbidity and mortality
in infants. Findings from these studies showed that children born
with LBW and VLBW children had signiﬁcantly lower lung function
[3,7] and volumes [6,27] along with increased bronchial hyper-
responsiveness [7] when compared to normal birth weight. How-
ever, approaches using dichotomized birth weight do not provide
information on whether there is linear relationship between birth
weight and lung function. Rona et al. investigated the association
between continuous birth weight and lung function and demon-
strated a positive linear association between birth weight adjusted
for gestational age and FEV1 and FVC at age 10 years in children of
5e11 years of age [8]. Our ﬁndings showing a positive association
between birth weight and FEV1 and FVC are consistent with those
of Rona et al. However, in contrast to our results, Rona et al. did not
ﬁnd any signiﬁcant association between birth weight and FEF25e75.
Table 1
Comparison of baseline characteristics for children with spirometry either at age 10 or 18 with total IOW cohort.
Participants Total IOW cohort (N ¼ 1536) Sample with spirometry either
at age 10 or 18 (N ¼ 1121)
p-value
n (%)/n (mean ± s.d.) n (%)/n (mean ± s.d.)
Sex Male 786 (51.2) 557 (49.7) 0.4499
Female 750 (48.8) 564 (50.3)
Maternal smoking Yes 384 (25.3) 253 (22.7) 0.1236
No 1137 (74.8) 864 (77.3)
Missing 15 4
Low birth weight Yes 61 (4.1) 36 (3.3) 0.3049
No 1433 (95.9) 1053 (96.7)
Missing 42 32
ETS at age 10 yrs Yes 561 (42.1) 440 (41.2) 0.6364
No 771 (57.9) 629 (58.8)
Missing 204 52
Admission to NICU Yes 142 (11.5) 92 (10.2) 0.3481
No 1092 (88.5) 808 (89.8)
Missing 302 221
Smoking at age 18 years Yes 368 (28.8) 276 (26.8) 0.3003
No 910 (71.2) 752 (73.2)
Missing 258 93
Socio-economic status Lowest 209 (15.4) 160 (14.6) 0.7796
Middle 1037 (76.4) 850 (77.6)
Highest 111 (8.2) 85 (7.8)
Missing 179 26
Maternal asthma Yes 163 (10.7) 76 (10.9) 0.8345
No 1355 (89.3) 618 (89.1)
Missing 18 4
Birth weight (kg) 1511 (3.4 ± 0.5) 1103 (3.4 ± 0.5) 0.3906
Missing 25 18
Height (cm) At age 10 yrs 1043 (138.9 ± 6.2) 1026 (138.9 ± 6.2) 0.3646
Missing 493 95
At age 18 yrs 994 (171.2 ± 9.5) 918 (171.0 ± 9.3) 0.5918
Missing 542 203
Weight (kg) At age 10 yrs 1043 (35.2 ± 7.5) 1026 (35.2 ± 7.5) 0.9616
Missing 493 95
At age 18 yrs 970 (67.8 ± 13.7) 897 (67.8 ± 13.6) 0.9909
Missing 566 224
BMI (kg/m2) At age 10 yrs 1043 (18.1 ± 3.0) 1026 (18.1 ± 2.9) 0.9307
Missing 493 95
At age 18 yrs 964 (23.2 ± 4.3) 896 (23.2 ± 4.3) 0.9291
Missing 572 225
IOW: Isle of Wight.
ETS: Environmental tobacco smoke.
NICU: Neonatal Intensive Care Unit.
BMI: Body Mass Index.
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patternwith asthma and lung function [9] and found that at 8 years
of age higher birth weight was strongly associated with higher FVC,
FEV1 and FEF25e75 z-scores and at age 15 years with higher FVC andTable 2
Association of birth weight, gestational age and gestational maternal smoking with lung
Predictor FEV1 (mL) FVC (m
Est. ± SE P-value Est. ± S
At 10 years of age (n ¼ 981)
Birth weight (kg)a 44.4 ± 17.3 0.0107 39.4 ±
Gestational age (weeks)b 2.9 ± 5.1 0.5672 4.0 ±
Maternal smoking during pregnancy: Yesc 7.4 ± 17.0 0.6664 6.3 ±
At 18 years of age (n ¼ 838)
Birth weight (kg)a 80.2 ± 38.5 0.0375 100.1 ±
Gestational age (weeks)b 11.2 ± 10.8 0.2995 3.8 ±
Maternal smoking during pregnancy: Yesc 42.4 ± 40.1 0.2907 109.4 ±
FEV1: Forced expiratory volume in one second.
FVC: Forced vital capacity.
FEF25e75: Forced expiratory ﬂow between 25% and 75% of forced vital capacity.
a Models adjusted for maternal smoking during pregnancy, sex, height, age, gestational
at 18 years of age, height  sex.
b Models adjusted for sex, height, age, maternal smoking during pregnancy, maternal h
age, height  sex.
c Models adjusted for sex, height, age, gestational age, maternal history of asthma, adreduced FEV1/FVC and FEF25e75/FVC ratios [9]. Our ﬁndings from
linear regression models at age 10 years are comparable to those of
Sonnenschein et al. at 8 years. However, our results using appro-
priate models for repeated measurements, such as linear mixedfunction: cross-sectional analysis.
L) FEV1/FVC (%) FEF25e75 (mL)
E P-value Est. ± SE P-value Est. ± SE P-value
18.1 0.0302 0.3 ± 0.4 0.4977 89.4 ± 41.3 0.0306
5.4 0.4617 0.3 ± 0.1 0.0477 19.1 ± 12.2 0.1178
18.0 0.7270 0.1 ± 0.4 0.9118 63.1 ± 40.8 0.1222
42.7 0.0193 0.4 ± 0.6 0.5131 90.4 ± 84.3 0.2839
12.0 0.7507 0.3 ± 0.2 0.1380 34.1 ± 23.6 0.1483
44.8 0.0149 1.3 ± 0.6 0.0421 88.8 ± 87.4 0.3099
age, maternal history of asthma, admission to Neonatal Intensive Care Unit, smoking
istory of asthma, admission to Neonatal Intensive Care Unit, smoking at 18 years of
mission to Neonatal Intensive Care Unit, smoking at 18 years of age, height  sex.
Table 3
Association of birth weight, gestational age and gestational maternal smoking with lung function: repeated-measurement analysis.
Predictor FEV1 (mL) FVC (mL) FEV1/FVC (%) FEF25e75 (mL)
Est. ± SE P-value Est. ± SE P-value Est. ± SE P-value Est. ± SE P-value
(n ¼ 1121) Birth weight (kg)a 42.6 ± 17.2 0.0145 35.0 ± 18.1 0.0536 0.1 ± 0.4 0.8747 95.5 ± 41.2 0.0207
Gestational age (weeks)b 3.1 ± 5.2 0.5515 3.3 ± 5.5 0.5484 0.2 ± 0.1 0.0885 18.7 ± 12.1 0.1242
Maternal smoking during pregnancy: Yesc 0.5 ± 17.0 0.9781 0.1 ± 18.0 0.9964 0.3 ± 0.4 0.4694 48.0 ± 39.9 0.2284
a Models adjusted for maternal smoking during pregnancy, sex, height, age, gestational age, maternal history of asthma, admission to Neonatal Intensive Care Unit, smoking
at 18 years of age, height  sex.
b Models adjusted for sex, height, age, maternal smoking during pregnancy, maternal history of asthma, admission to Neonatal Intensive Care Unit, smoking at 18 years of
age, height  sex.
c Models adjusted for sex, height, age, gestational age, maternal history of asthma, admission to Neonatal Intensive Care Unit, smoking at 18 years of age, height  sex.
Gestational age 
FEV1 at age 18 
years 
FEV1 at age 10 
years 
Maternal 
smoking during 
pregnancy 
Sex: Female  
Height at age 18 
years 
Height at age 10 
years 
Birth weight 
0.47 
-0.09
0.60
0.51
-0.10
0.07
-0.27
0.45
0.07
0.08
-0.34 
-0.15 
Weight at age 10 
years 
Fig. 1. Path diagram - association of birth weight, gestational age and gestational maternal smoking with FEV1. This analytical path diagram shows statistically signiﬁcant stan-
dardized direct effects (path coefﬁcient) of birth weight, gestational age and maternal smoking status during pregnancy on FEV1 at 10 and 18 years.
Gestational age 
FEF25-75 at age 18 
years 
FEF25-75 at age 10 
years 
Maternal 
smoking during 
pregnancy 
Sex: Female  
Height at age 18 
years 
Height at age 10 
years 
Birth weight 
0.47 
-0.09 
0.30
0.59
0.01
-0.09
0.19
0.10
-0.37 
-0.15 
-0.05
Fig. 2. Path diagram - association of birth weight, gestational age and gestational maternal smoking with FEF25e75. This analytical path diagram shows statistically signiﬁcant
standardized direct effects (path coefﬁcient) of birth weight, gestational age and maternal smoking status during pregnancy on FEF25e75 at 10 and 18 years.
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P. Balte et al. / Respiratory Medicine 121 (2016) 13e2018models and path analysis, showed that birth weight also had pos-
itive associationwith FEV1 and FEF25e75 in addition to FVC, at age 18
years.
4.2. Relationship between maternal smoking during pregnancy,
gestational age, birth weight and lung function: path analysis
The results from previous studies exploring the relationship
between maternal smoking during pregnancy and lung function
are mixed. Some studies have suggested reduction in lung function
in children exposed to maternal smoking in-utero [17,28] while
other studies reported no such association [19,29]. While most
studies have not adjusted for birth weight in their statistical
models, Hayatbakhsh et al. found a reduction in lung function in
boys of age 21 years even after adjusting for birth weight [30]. One
can argue that birth weight and maternal smoking are in the same
‘causal pathway’ related to intra-uterine growth retardation and
both should not be used in the same model. In these situations, use
of traditional analysis does not allow to discern the independent
effects of risk factors (maternal smoking and birth weight) on the
outcome (lung function). In standard regression analysis each var-
iable is identiﬁed as either risk or effect prior to analysis and sta-
tistical relationship between these variables are based on a
conditional expected value. These models do not take into
consideration the temporal sequence and thus are ill-suited for
modeling relationships which are composed of effects mediated
through intervening variables. Linear path analyses on the other
hand accommodate intervening variables in the analysis [31]. Using
path analysis, we found that exposure tomaternal smoking in-utero
was associated directly with reduction in FEF25e75 and increase in
FVC. These ﬁndings were not evident in linear mixed models.
Additionally, path analysis also showed that even though birth
weight did not have any signiﬁcant direct effect on FVC at age 18
years it did have signiﬁcant indirect effect [Table 2 online
supplement].
One of the main ﬁndings of our study was the positive associ-
ation between birth weight and FEF25e75 at age 18 years which
measures airﬂow in small airways; this association was not shown
by Sonnenschein et al. in adolescents of age 15 years [9]. Birth
weight is a surrogate marker for intrauterine growth and gesta-
tional age andmaternal smoking during pregnancy have signiﬁcant
adverse effect on birth weight. Hence the association between birth
weight and lung function may reﬂect the underlying association
between gestational age and maternal smoking during pregnancy
with lung function. Previous studies have shown that higher
gestational age was associated with higher FEF25e75 [9] and
maternal smoking during pregnancy was associated with reduced
FEF25e75 [17,28,30]. Our path analysis results are consistent with
these ﬁndings [Fig. 2]. The underlying patho-physiological mech-
anisms are not fully understood. Although histopathological
studies have shown that broncho-pulmonary dysplasia, a hallmark
of respiratory distress syndrome in premature babies, is charac-
terized by formation of hyaline membrane in small airways,
enlargement and oversimpliﬁcation of alveoli and increase in
interstitial thickening leading to a reduction in elastic recoil [32,33].
Additionally, an animal model presented by Rehan et al. to study
the effects of maternal smoking on fetal lung development showed
that in-utero exposure to tobacco smoke alters the normal ho-
meostatic epithelial-mesenchymal interaction in the developing
alveolus, resulting in production of myoﬁbroblasts in larger as well
as smaller airways, which is a common ﬁnding in asthma and
chronic lung disease [34].
Our results from cross-sectional analysis at age 18 years
(Table 2) and path analysis (Table 2 in online supplement) showed a
positive association between maternal smoking and higher FVC,comparable to the previous studies, which have also shown an
association between maternal smoking during pregnancy and
higher FVC in children [26,35,36]. Studies have suggested that
maternal smoking during pregnancy or exposure to parental
smoking during early childhood may cause disproportional growth
of lung parenchyma and airways known as dysynaptic growth of
lungs in children [35,37e39].
One of the major limitations of this study is that the information
on smoking during pregnancy was self-reported and was not
veriﬁed by objective measurements like urine cotinine levels.
Studies have shown that self-reported smoking status during
pregnancy grossly underestimates the true prevalence of smoking
during pregnancy [40,41]. Therefore, it is likely that the prevalence
of smoking during pregnancy in our study is underestimated which
may in turn bias our ﬁndings related to maternal smoking and lung
function towards null. The second important limitation of this
study was that there was a lack of information on number of cig-
arettes smoked per day and duration of smoking bymothers during
pregnancy. Therefore, wewere not able to assess the dose-response
relationship between in-utero exposure to smoking and lung
function.
The strength of this study is that we analyzed lung function
measurements in pre-adolescents and adolescents, thus covering
an important period of lung development. In addition, cohort
members who participated in lung function testing were not
different from the participant of the overall birth cohort. To our
knowledge no other study has investigated the risk of gestational
and neonatal conditions on lung function in the adolescence with
repeated measurements and path-analytical models. As informa-
tion on birth weight, gestational age and maternal smoking during
pregnancy were recorded soon after birth; a recall bias is unlikely.
To address a few missing information, multiple imputations were
used. This is a robust method to overcome the problem of missing
data and to generate unbiased estimates. We also used linear mixed
models which weremore appropriate than simple linear regression
models as they also consider individual change in lung function
across time. Use of path analysis allowed us to include intervening
variables in models whose inclusion in linear mixed models would
normally produce biased estimates.
5. Conclusions
In conclusion, we found that higher birth weight was signiﬁ-
cantly associated, either directly or indirectly, with higher FEV1, FVC
and FEF25e75 in adolescents at age 18 years. Though we did not ﬁnd
signiﬁcant associations between maternal smoking and lung
function through standard linear mixed models, the more appro-
priate path analysis showed that gestational smoke exposure does
have negative effects on FEV1/FVC ratio due to increase in FVC and
on FEF25e75 at age 18 years. With path analysis, we gained insight
and better understanding about the underlying links between
various prenatal and early childhood factors that affect lung func-
tion. Our results suggest that the beneﬁcial effects of favorable fetal
growth, which is reﬂected by birth weight, goes beyond lung
function changes in early childhood years. Future research inves-
tigating effects of gestational smoking, birth weight and growth on
lung function should consider employing path analyses models to
disentangle the complex relationships between these determinants
of lung function.
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